The profiles of patients using INH for LTBI reflect these guidelines, in which INH was predominantly administered to individuals at greater risk for developing the active disease such as those living with HIV, adult and child contacts of patients with pulmonary TB, patients initiating anti-tumor necrosis factor treatment, patients undergoing dialysis, and those preparing for transplantation6,.101. The gene discussed is TNF; the disease is pulmonary tuberculosis.